MBOAT7 and metabolic dysfunction-associated steatotic liver disease: MBOAT7 variants also increase the susceptibility to liver disorders including liver cirrhosis and non-alcoholic fatty liver disease (NAFLD) by inducing a reduction in its expression in liver [107–109].